Ethan Russo Joins True Terpenes Scientific Advisory Board
PORTLAND, April, 2020 – Dr. Ethan Russo has joined the Scientific Advisory Board (SAB) at True Terpenes, a leader in cannabis and terpene formulation research.
“We are incredibly excited to work with Dr. Russo to expand research and offer products that can help people,” True Terpenes CEO Chris Campagna said. “His research on the entourage effect was part of the inspiration for the founding of True Terpenes. We can’t wait to begin collaborating and expanding our product offerings.”
Dr. Russo is a medical doctor and cannabis research pioneer. He has written a number of papers that set the tone for the intellectual discussion on medical cannabis and its effects including Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. This paper was an introduction to the entourage effect, terpenes and cannabis for many scientists, doctors and laypeople.
The entourage effect is the unified theory of how the compounds in cannabis and our bodies interact synergistically to form the therapeutic and subjective effects cannabis is known for. These interactions occur through a variety of bodily systems and compounds including and beyond cannabinoids including terpenes and other phytochemicals.
Dr. Russo was a Senior Medical Advisor for GW Pharmaceuticals research on cannabis therapies including Sativex and Epidiolex. Epidiolex is the first FDA approved botanically-derived cannabis medication.
Despite the availability of a cannabis-derived FDA approved drug and ongoing medical research, there is still very little data confirming the mechanisms of the entourage effect. Dr. Russo and True Terpenes plan to investigate how cannabinoids, terpenes and other phytochemicals interact to create the unique effects each cultivar is known for.
“It was difficult in past times to identify sources of pure compounds, particularly of botanical origin, let alone meeting scientific safety standards or organic cultural origin. All these issues have changed with the advent of True Terpenes, a company that has been dedicated from its beginning to raising industry standards and applying Good Manufacturing Practice to their entire line of products,” said Dr. Russo, a founding member of the True Terpenes Scientific Advisory Board.
This research will lead to medical advancements and understanding, while simultaneously improving the ability of medical and recreational cannabis companies to give users predictable, repeatable and enjoyable experiences. True Terpenes plans to integrate research findings into future additions to its robust catalog of functional flavors and terpene profiles.
About True Terpenes
True Terpenes is the industry-leading producer of GMP/ISO/FSSC-certified, effects-based terpenes and terpenoids from hemp and other plants for the alcohol, beverage, cannabis, cosmetic, food, industrial and pharmaceutical use. The company uses advanced scientific analysis to identify terpenes and other compounds in the cannabis plant for recreation utilizing other botanicals and cannabis-derived ingredients. This will allow scalable solutions for companies in a variety of industries that wish to leverage cannabis and regulatory compliance, but have limited experience or knowledge of either space.
Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.